In this issue of Blood, Takahashi et al provide evidence that cancer gene mutations in patients with chronic lymphocytic leukemia (CLL) have a prognostic role and significantly affect response to lenalidomide-based therapy.1
Gene mutations in lenalidomide-treated CLL / Mauro, Francesca Romana; Foà, Robin. - In: BLOOD. - ISSN 0006-4971. - 131:16(2018), pp. 1769-1771. [10.1182/blood-2018-02-830406]
Gene mutations in lenalidomide-treated CLL
Mauro, Francesca Romana;Foà, Robin
2018
Abstract
In this issue of Blood, Takahashi et al provide evidence that cancer gene mutations in patients with chronic lymphocytic leukemia (CLL) have a prognostic role and significantly affect response to lenalidomide-based therapy.1File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
